Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Adv

- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platformFRAMINGHAM, MA / ACCESSWIRE / January 17, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing inn...

Related Keywords

Ukraine ,Russia ,Russian ,Allan Tsung ,Jeffrey Eisenberg ,Xenetic Biosciences ,Jenene Thomas ,Research Funding Agreement ,Facebook ,Company Dnase ,Company Scientific Advisory Board ,Linkedin ,Twitter ,School Of Medicine ,University Of Virginia ,Xenetic Biosciences Inc ,Nasdaq ,Department Of Surgery ,Material Transfer Agreement ,Scientific Advisory Board ,Chief Executive Officer ,Private Securities Litigation Reform Act ,